Iliuta, Ioan-Andrei
Win, Aung Zaw
Lanktree, Matthew B.
Lee, Seung Heyck
Pourafkari, Marina
Nasri, Fatemeh
Guiard, Elsa
Haghighi, Amirreza
He, Ning
Ingram, Alistair
Quist, Crystal
Hillier, David
Khalili, Korosh
Pei, York
Funding for this research was provided by:
Canadian Institutes of Health Research (CAN-SOLVE-CKD SCA-145103)
Article History
Received: 8 April 2022
Accepted: 10 November 2022
First Online: 20 February 2023
Competing interests
: MBL has received compensation for participation as a speaker and an advisory board member with Otsuka, Reata, Bayer, and Sanofi-Genzyme Pharmaceuticals. YP has received compensation for participation in advisory boards for Otsuka, Sanofi-Genzyme, and Reata Pharmaceuticals. The remaining authors declare no competing interests.